Surveillance is a "good thing," at least if you're an epidemiologist. But The agenda of the developed countries, then (and these clearly include the United States in the present instance), is close monitoring of a rather important series of events in the rapid evolution of antibiotic resistance. This probably fits best under determining the needfor public health action in the list of uses of surveillance programmes given above, since ideally the developed countries would be interested in intervention in the less developed countries, on the grounds that it's better to stop it there than stop it here. For a surveillance project like GASP, such a goal would imply increased attention to the completeness of regional reporting and to the comparability of sampling plans and reporting locations between time periods. Viewed from the other perspective, improvement of treatment in the less developed countries in the region would imply increased representativeness of the data at national levels as well as the continuation of GASP's technical assistance efforts. The surveillance goal here would be to assess the effectiveness of programmes 
